Home › Compare › DKSC vs ORCC

DKSC vs ORCC: Dividend Comparison 2026

DKSC yields 400000.00% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DKSC wins by $5.011119029548644e+32M in total portfolio value
10 years
DKSC
DKSC
● Live price
400000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.011119029548644e+32M
Annual income
$500,865,583,351,836,840,000,000,000,000,000,000,000.00
Full DKSC calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — DKSC vs ORCC

📍 DKSC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDKSCORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DKSC + ORCC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
DKSC pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DKSC
Annual income on $10K today (after 15% tax)
$34,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, DKSC beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DKSC + ORCC for your $10,000?

DKSC: 50%ORCC: 50%
100% ORCC50/50100% DKSC
Portfolio after 10yr
$2.505559514774322e+32M
Annual income
$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr
Blended yield
99.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

DKSC
No analyst data
Altman Z
-4.2
Piotroski
2/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DKSC buys
0
ORCC buys
0
No recent congressional trades found for DKSC or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDKSCORCC
Forward yield400000.00% ✓9.79%
Annual dividend / share$2.00 ✓$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0% ✓-50%
Portfolio after 10y$5.011119029548644e+32M$21.4K ✓
Annual income after 10y$500,865,583,351,836,840,000,000,000,000,000,000,000.00 ✓$1.04
Total dividends collected$5.010957816668433e+32M ✓$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: DKSC vs ORCC ($10,000, DRIP)

YearDKSC PortfolioDKSC Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$40,010,700$40,000,000.00$11,190$489.61+$40.00M → DKSC
2$149,615,521,729$149,572,710,280.37$12,229$256.01+$149615.51M → DKSC
3$522,880,052,725,200$522,719,964,116,949.25$13,216$130.74+$522880052.71M → DKSC
4$1,707,862,989,289,045,000$1,707,303,507,632,628,700.00$14,207$66.02+$1707862989289.03M → DKSC
5$5,213,509,402,845,684,000,000$5,211,681,989,447,144,000,000.00$15,234$33.17+$5213509402845684.00M → DKSC
6$14,874,219,058,409,543,000,000,000$14,868,640,603,348,497,000,000,000.00$16,317$16.62+$14874219058409543680.00M → DKSC
7$39,661,196,234,050,755,000,000,000,000$39,645,280,819,658,260,000,000,000,000.00$17,468$8.32+$3.966119623405075e+22M → DKSC
8$98,838,436,350,327,300,000,000,000,000,000$98,795,998,870,356,880,000,000,000,000,000.00$18,695$4.16+$9.88384363503273e+25M → DKSC
9$230,205,236,474,344,900,000,000,000,000,000,000$230,099,479,347,450,050,000,000,000,000,000,000.00$20,006$2.08+$2.302052364743449e+29M → DKSC
10$501,111,902,954,864,400,000,000,000,000,000,000,000$500,865,583,351,836,840,000,000,000,000,000,000,000.00$21,407$1.04+$5.011119029548644e+32M → DKSC

DKSC vs ORCC: Complete Analysis 2026

DKSC — Stock

Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company. It cultivates cannabis; and operates an online sales portal for CBD products. The company also manages distribution channel programs in the retail distribution, reselling, and direct sales market segments. Dakshidin Corporation, Inc. was formerly known as Avrada, Inc. and changed its name to Dakshidin Corporation, Inc. in February 2007. The company is based in Miami, Florida with additional offices in Las Vegas, Nevada.

Full DKSC Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this DKSC vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DKSC vs SCHDDKSC vs JEPIDKSC vs ODKSC vs KODKSC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.